BIOMAKERS, a precision medicine and oncology intelligence company headquartered in San Francisco, today announced the closing ...

Commentary: I see the human cost of this “functional uninsurance” every week: Patients who technically have coverage but are ...

The coverage milestone follows the American Medical Association's implementation of new Category I CPT payment code 75577 for Heartflow Plaque Analysis effective January 1, 2026. Heartflow Plaque ...

Modern smart collars have evolved from simple GPS trackers to sophisticated biometric instruments capable of early disease ...

Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative Growth of 54% Compared to Prior Quarter; Exiting 2025 with Approximately $35 Million ...

Tal Parnes, Chairman of the Board of Inspira Technologies, stated: “The contemplated acquisition of this liquid biopsy platform represents a significant value inflection point for Inspira, adding a ...

Taipei, Taiwan, Jan. 06, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited ("YD Bio” or the "Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ...

All-share acquisition positions Inspira to expand into a multi-billion dollar diagnostics market with a development-ready innovative technology; transaction structured to include significant ...

A new imaging technology can distinguish cancerous tissue from healthy cells by detecting ultra-weak light signals. It relies on nanoparticles that bind to tumor markers, making cancerous areas easier ...

If you encounter the ‘Your current version of diagnostics is not up to date’ error message, go to the URL mentioned in the error message and try downloading the ...